As per the Disclosure attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cian Healthcare Ltd has received trading approval from BSE for 2.50 crore fully paid-up equity shares of Rs. 10 face value each, effective April 2, 2026. These shares were allotted under the Resolution Plan approved by the National Company Law Tribunal (NCLT), Mumbai Bench on December 18, 2025, under the Insolvency and Bankruptcy Code, 2016. Of these, 12.5 lakh shares were allotted to public shareholders in lieu of their earlier shareholding (with a reduction in paid-up capital), and 2.375 crore shares were allotted to the promoters. The Successful Resolution Applicant was Mr. Pradeep Kumar Jain. This marks the formal completion of the company's revival process and its return to active trading on BSE.
This is a positive turning point — Cian Healthcare has formally emerged from the insolvency resolution process and its shares will resume trading on BSE from April 2, 2026. However, existing public shareholders should note that their shareholding has been reduced as part of the resolution plan. The promoter group now holds a significantly larger stake, which may influence future control and decision-making.